Company Filing History:
Years Active: 2006-2012
Title: Sanmao Kang: Innovator in Breast Cancer Research
Introduction
Sanmao Kang is a prominent inventor based in Richmond, California, known for his significant contributions to breast cancer research. With a total of three patents to his name, Kang’s work focuses on identifying genetic markers associated with metastatic potential in cancer cells, specifically breast cancer cells.
Latest Patents
Kang's latest patents delve into the realm of genetic research with a specific emphasis on a polynucleotide sequence referred to as SEQ ID NO:1. This sequence is notably associated with the risk of metastasis in tumors. The methods outlined in his patents provide crucial techniques for determining whether a tissue sample from a tumor expresses a polypeptide or mRNA encoded by this specific polynucleotide sequence. The implications of his work offer potential therapeutic methods and compositions that can significantly impact breast cancer treatment.
Career Highlights
Throughout his career, Sanmao Kang has collaborated with esteemed organizations in the pharmaceutical and diagnostic fields. Notably, he has worked with Novartis Vaccines & Diagnostics and Chiron Corporation, where he applied his innovative thinking to advance cancer research and diagnostics.
Collaborations
Kang has had the opportunity to collaborate with distinguished colleagues, including Joerg Kaufmann and Greg Harrowe. Their combined expertise has contributed to the development of groundbreaking research, leading to innovations that aim to enhance cancer treatment strategies.
Conclusion
Sanmao Kang's pioneering work in identifying genetic markers for breast cancer underscores his substantial impact in the field of cancer research. Through his innovations, he is paving the way for new therapeutic options and enhancing the understanding of metastatic behavior in breast cancer. His contributions exemplify the essential role of inventors in advancing medical science and improving patient outcomes.